 | • レポートコード：GIR201108916 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、ソマトスタチン受容体2型の世界市場を調査対象にし、ソマトスタチン受容体2型の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（CRN-00808、酢酸ランレオチド、PRL-2903、その他）、用途別分析（ホルモン障害、腫瘍、代謝障害、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Amryt Pharma plc、Ipsen SA、Crinetics Pharmaceuticals Inc、Zucara Therapeutics Inc、Daewoong Pharmaceutical Co Ltd、Strongbridge Biopharma plc、Progenics Pharmaceuticals Inc ・メーカー別販売量、売上、市場シェア ・ソマトスタチン受容体2型の地域別市場分析 ・ソマトスタチン受容体2型の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・ソマトスタチン受容体2型のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・ソマトスタチン受容体2型のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・ソマトスタチン受容体2型の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・ソマトスタチン受容体2型の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・ソマトスタチン受容体2型の種類別市場規模2015-2020：CRN-00808、酢酸ランレオチド、PRL-2903、その他 ・ソマトスタチン受容体2型の用途別市場規模2015-2020：ホルモン障害、腫瘍、代謝障害、その他 ・ソマトスタチン受容体2型の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Somatostatin Receptor Type 2 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Somatostatin Receptor Type 2 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Somatostatin Receptor Type 2 market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Somatostatin Receptor Type 2 market has been segmented into
CRN-00808
Lanreotide Acetate
PRL-2903
Others
By Application, Somatostatin Receptor Type 2 has been segmented into:
Hormonal Disorder
Oncology
Metabolic Disorder
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Somatostatin Receptor Type 2 market presented in the report. This section sheds light on the sales growth of different regional and country-level Somatostatin Receptor Type 2 markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Somatostatin Receptor Type 2 market.
The report offers in-depth assessment of the growth and other aspects of the Somatostatin Receptor Type 2 market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Somatostatin Receptor Type 2 Market Share Analysis
Somatostatin Receptor Type 2 competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Somatostatin Receptor Type 2 sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Somatostatin Receptor Type 2 sales, revenue and market share for each player covered in this report.
The major players covered in Somatostatin Receptor Type 2 are:
Amryt Pharma plc
Ipsen SA
Crinetics Pharmaceuticals Inc
Zucara Therapeutics Inc
Daewoong Pharmaceutical Co Ltd
Strongbridge Biopharma plc
Progenics Pharmaceuticals Inc
Among other players domestic and global, Somatostatin Receptor Type 2 market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Somatostatin Receptor Type 2 product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Somatostatin Receptor Type 2, with price, sales, revenue and global market share of Somatostatin Receptor Type 2 in 2018 and 2019.
Chapter 3, the Somatostatin Receptor Type 2 competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Somatostatin Receptor Type 2 breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Somatostatin Receptor Type 2 market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Somatostatin Receptor Type 2 sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Somatostatin Receptor Type 2 Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Somatostatin Receptor Type 2 Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 CRN-00808
1.2.3 Lanreotide Acetate
1.2.4 PRL-2903
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Somatostatin Receptor Type 2 Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hormonal Disorder
1.3.3 Oncology
1.3.4 Metabolic Disorder
1.3.5 Others
1.4 Overview of Global Somatostatin Receptor Type 2 Market
1.4.1 Global Somatostatin Receptor Type 2 Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Amryt Pharma plc
2.1.1 Amryt Pharma plc Details
2.1.2 Amryt Pharma plc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Amryt Pharma plc SWOT Analysis
2.1.4 Amryt Pharma plc Product and Services
2.1.5 Amryt Pharma plc Somatostatin Receptor Type 2 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Ipsen SA
2.2.1 Ipsen SA Details
2.2.2 Ipsen SA Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Ipsen SA SWOT Analysis
2.2.4 Ipsen SA Product and Services
2.2.5 Ipsen SA Somatostatin Receptor Type 2 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Crinetics Pharmaceuticals Inc
2.3.1 Crinetics Pharmaceuticals Inc Details
2.3.2 Crinetics Pharmaceuticals Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Crinetics Pharmaceuticals Inc SWOT Analysis
2.3.4 Crinetics Pharmaceuticals Inc Product and Services
2.3.5 Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 2 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Zucara Therapeutics Inc
2.4.1 Zucara Therapeutics Inc Details
2.4.2 Zucara Therapeutics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Zucara Therapeutics Inc SWOT Analysis
2.4.4 Zucara Therapeutics Inc Product and Services
2.4.5 Zucara Therapeutics Inc Somatostatin Receptor Type 2 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Daewoong Pharmaceutical Co Ltd
2.5.1 Daewoong Pharmaceutical Co Ltd Details
2.5.2 Daewoong Pharmaceutical Co Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Daewoong Pharmaceutical Co Ltd SWOT Analysis
2.5.4 Daewoong Pharmaceutical Co Ltd Product and Services
2.5.5 Daewoong Pharmaceutical Co Ltd Somatostatin Receptor Type 2 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Strongbridge Biopharma plc
2.6.1 Strongbridge Biopharma plc Details
2.6.2 Strongbridge Biopharma plc Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Strongbridge Biopharma plc SWOT Analysis
2.6.4 Strongbridge Biopharma plc Product and Services
2.6.5 Strongbridge Biopharma plc Somatostatin Receptor Type 2 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Progenics Pharmaceuticals Inc
2.7.1 Progenics Pharmaceuticals Inc Details
2.7.2 Progenics Pharmaceuticals Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Progenics Pharmaceuticals Inc SWOT Analysis
2.7.4 Progenics Pharmaceuticals Inc Product and Services
2.7.5 Progenics Pharmaceuticals Inc Somatostatin Receptor Type 2 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Somatostatin Receptor Type 2 Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Somatostatin Receptor Type 2 Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Somatostatin Receptor Type 2 Manufacturer Market Share in 2019
3.3.2 Top 6 Somatostatin Receptor Type 2 Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Somatostatin Receptor Type 2 Sales, Revenue and Market Share by Regions
4.1.1 Global Somatostatin Receptor Type 2 Sales and Market Share by Regions (2015-2020)
4.1.2 Global Somatostatin Receptor Type 2 Revenue and Market Share by Regions (2015-2020)
4.2 North America Somatostatin Receptor Type 2 Sales and Growth Rate (2015-2020)
4.3 Europe Somatostatin Receptor Type 2 Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Somatostatin Receptor Type 2 Sales and Growth Rate (2015-2020)
4.5 South America Somatostatin Receptor Type 2 Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Somatostatin Receptor Type 2 Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Somatostatin Receptor Type 2 Sales, Revenue and Market Share by Country
5.1.1 North America Somatostatin Receptor Type 2 Sales and Market Share by Country (2015-2020)
5.1.2 North America Somatostatin Receptor Type 2 Revenue and Market Share by Country (2015-2020)
5.2 United States Somatostatin Receptor Type 2 Sales and Growth Rate (2015-2020)
5.3 Canada Somatostatin Receptor Type 2 Sales and Growth Rate (2015-2020)
5.4 Mexico Somatostatin Receptor Type 2 Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Somatostatin Receptor Type 2 Sales, Revenue and Market Share by Country
6.1.1 Europe Somatostatin Receptor Type 2 Sales and Market Share by Country (2015-2020)
6.1.2 Europe Somatostatin Receptor Type 2 Revenue and Market Share by Country (2015-2020)
6.2 Germany Somatostatin Receptor Type 2 Sales and Growth Rate (2015-2020)
6.3 UK Somatostatin Receptor Type 2 Sales and Growth Rate (2015-2020)
6.4 France Somatostatin Receptor Type 2 Sales and Growth Rate (2015-2020)
6.5 Russia Somatostatin Receptor Type 2 Sales and Growth Rate (2015-2020)
6.6 Italy Somatostatin Receptor Type 2 Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Somatostatin Receptor Type 2 Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Somatostatin Receptor Type 2 Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Somatostatin Receptor Type 2 Revenue and Market Share by Regions (2015-2020)
7.2 China Somatostatin Receptor Type 2 Sales and Growth Rate (2015-2020)
7.3 Japan Somatostatin Receptor Type 2 Sales and Growth Rate (2015-2020)
7.4 Korea Somatostatin Receptor Type 2 Sales and Growth Rate (2015-2020)
7.5 India Somatostatin Receptor Type 2 Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Somatostatin Receptor Type 2 Sales and Growth Rate (2015-2020)
7.7 Australia Somatostatin Receptor Type 2 Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Somatostatin Receptor Type 2 Sales, Revenue and Market Share by Country
8.1.1 South America Somatostatin Receptor Type 2 Sales and Market Share by Country (2015-2020)
8.1.2 South America Somatostatin Receptor Type 2 Revenue and Market Share by Country (2015-2020)
8.2 Brazil Somatostatin Receptor Type 2 Sales and Growth Rate (2015-2020)
8.3 Argentina Somatostatin Receptor Type 2 Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Somatostatin Receptor Type 2 Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Somatostatin Receptor Type 2 Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Somatostatin Receptor Type 2 Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Somatostatin Receptor Type 2 Sales and Growth Rate (2015-2020)
9.3 Turkey Somatostatin Receptor Type 2 Sales and Growth Rate (2015-2020)
9.4 Egypt Somatostatin Receptor Type 2 Sales and Growth Rate (2015-2020)
9.5 South Africa Somatostatin Receptor Type 2 Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Somatostatin Receptor Type 2 Sales and Market Share by Type (2015-2020)
10.2 Global Somatostatin Receptor Type 2 Revenue and Market Share by Type (2015-2020)
10.3 Global Somatostatin Receptor Type 2 Price by Type (2015-2020)
11 Global Somatostatin Receptor Type 2 Market Segment by Application
11.1 Global Somatostatin Receptor Type 2 Sales Market Share by Application (2015-2020)
11.2 Global Somatostatin Receptor Type 2 Revenue Market Share by Application (2015-2020)
11.3 Global Somatostatin Receptor Type 2 Price by Application (2015-2020)
12 Market Forecast
12.1 Global Somatostatin Receptor Type 2 Sales, Revenue and Growth Rate (2021-2025)
12.2 Somatostatin Receptor Type 2 Market Forecast by Regions (2021-2025)
12.2.1 North America Somatostatin Receptor Type 2 Market Forecast (2021-2025)
12.2.2 Europe Somatostatin Receptor Type 2 Market Forecast (2021-2025)
12.2.3 Asia-Pacific Somatostatin Receptor Type 2 Market Forecast (2021-2025)
12.2.4 South America Somatostatin Receptor Type 2 Market Forecast (2021-2025)
12.2.5 Middle East & Africa Somatostatin Receptor Type 2 Market Forecast (2021-2025)
12.3 Somatostatin Receptor Type 2 Market Forecast by Type (2021-2025)
12.3.1 Global Somatostatin Receptor Type 2 Sales Forecast by Type (2021-2025)
12.3.2 Global Somatostatin Receptor Type 2 Market Share Forecast by Type (2021-2025)
12.4 Somatostatin Receptor Type 2 Market Forecast by Application (2021-2025)
12.4.1 Global Somatostatin Receptor Type 2 Sales Forecast by Application (2021-2025)
12.4.2 Global Somatostatin Receptor Type 2 Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Somatostatin Receptor Type 2 Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Somatostatin Receptor Type 2 by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Somatostatin Receptor Type 2 Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Amryt Pharma plc Basic Information, Manufacturing Base and Competitors
Table 8. Amryt Pharma plc Somatostatin Receptor Type 2 Major Business
Table 9. Amryt Pharma plc Somatostatin Receptor Type 2 Total Revenue (USD Million) (2018-2019)
Table 10. Amryt Pharma plc SWOT Analysis
Table 11. Amryt Pharma plc Somatostatin Receptor Type 2 Product and Services
Table 12. Amryt Pharma plc Somatostatin Receptor Type 2 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Ipsen SA Basic Information, Manufacturing Base and Competitors
Table 14. Ipsen SA Somatostatin Receptor Type 2 Major Business
Table 15. Ipsen SA Somatostatin Receptor Type 2 Total Revenue (USD Million) (2018-2019)
Table 16. Ipsen SA SWOT Analysis
Table 17. Ipsen SA Somatostatin Receptor Type 2 Product and Services
Table 18. Ipsen SA Somatostatin Receptor Type 2 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Crinetics Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 20. Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 2 Major Business
Table 21. Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 2 Total Revenue (USD Million) (2018-2019)
Table 22. Crinetics Pharmaceuticals Inc SWOT Analysis
Table 23. Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 2 Product and Services
Table 24. Crinetics Pharmaceuticals Inc Somatostatin Receptor Type 2 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Zucara Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 26. Zucara Therapeutics Inc Somatostatin Receptor Type 2 Major Business
Table 27. Zucara Therapeutics Inc Somatostatin Receptor Type 2 Total Revenue (USD Million) (2018-2019)
Table 28. Zucara Therapeutics Inc SWOT Analysis
Table 29. Zucara Therapeutics Inc Somatostatin Receptor Type 2 Product and Services
Table 30. Zucara Therapeutics Inc Somatostatin Receptor Type 2 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Daewoong Pharmaceutical Co Ltd Basic Information, Manufacturing Base and Competitors
Table 32. Daewoong Pharmaceutical Co Ltd Somatostatin Receptor Type 2 Major Business
Table 33. Daewoong Pharmaceutical Co Ltd Somatostatin Receptor Type 2 Total Revenue (USD Million) (2018-2019)
Table 34. Daewoong Pharmaceutical Co Ltd SWOT Analysis
Table 35. Daewoong Pharmaceutical Co Ltd Somatostatin Receptor Type 2 Product and Services
Table 36. Daewoong Pharmaceutical Co Ltd Somatostatin Receptor Type 2 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Strongbridge Biopharma plc Basic Information, Manufacturing Base and Competitors
Table 38. Strongbridge Biopharma plc Somatostatin Receptor Type 2 Major Business
Table 39. Strongbridge Biopharma plc Somatostatin Receptor Type 2 Total Revenue (USD Million) (2018-2019)
Table 40. Strongbridge Biopharma plc SWOT Analysis
Table 41. Strongbridge Biopharma plc Somatostatin Receptor Type 2 Product and Services
Table 42. Strongbridge Biopharma plc Somatostatin Receptor Type 2 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Progenics Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 44. Progenics Pharmaceuticals Inc Somatostatin Receptor Type 2 Major Business
Table 45. Progenics Pharmaceuticals Inc Somatostatin Receptor Type 2 Total Revenue (USD Million) (2018-2019)
Table 46. Progenics Pharmaceuticals Inc SWOT Analysis
Table 47. Progenics Pharmaceuticals Inc Somatostatin Receptor Type 2 Product and Services
Table 48. Progenics Pharmaceuticals Inc Somatostatin Receptor Type 2 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Global Somatostatin Receptor Type 2 Sales by Manufacturer (2018-2019) (K Pcs)
Table 50. Global Somatostatin Receptor Type 2 Revenue by Manufacturer (2018-2019) (USD Million)
Table 51. Global Somatostatin Receptor Type 2 Sales by Regions (2015-2020) (K Pcs)
Table 52. Global Somatostatin Receptor Type 2 Sales Market Share by Regions (2015-2020)
Table 53. Global Somatostatin Receptor Type 2 Revenue by Regions (2015-2020) (USD Million)
Table 54. North America Somatostatin Receptor Type 2 Sales by Countries (2015-2020) (K Pcs)
Table 55. North America Somatostatin Receptor Type 2 Sales Market Share by Countries (2015-2020)
Table 56. North America Somatostatin Receptor Type 2 Revenue by Countries (2015-2020) (USD Million)
Table 57. North America Somatostatin Receptor Type 2 Revenue Market Share by Countries (2015-2020)
Table 58. Europe Somatostatin Receptor Type 2 Sales by Countries (2015-2020) (K Pcs)
Table 59. Europe Somatostatin Receptor Type 2 Sales Market Share by Countries (2015-2020)
Table 60. Europe Somatostatin Receptor Type 2 Revenue by Countries (2015-2020) (USD Million)
Table 61. Asia-Pacific Somatostatin Receptor Type 2 Sales by Regions (2015-2020) (K Pcs)
Table 62. Asia-Pacific Somatostatin Receptor Type 2 Sales Market Share by Regions (2015-2020)
Table 63. Asia-Pacific Somatostatin Receptor Type 2 Revenue by Regions (2015-2020) (USD Million)
Table 64. South America Somatostatin Receptor Type 2 Sales by Countries (2015-2020) (K Pcs)
Table 65. South America Somatostatin Receptor Type 2 Sales Market Share by Countries (2015-2020)
Table 66. South America Somatostatin Receptor Type 2 Revenue by Countries (2015-2020) (USD Million)
Table 67. South America Somatostatin Receptor Type 2 Revenue Market Share by Countries (2015-2020)
Table 68. Middle East & Africa Somatostatin Receptor Type 2 Sales by Countries (2015-2020) (K Pcs)
Table 69. Middle East & Africa Somatostatin Receptor Type 2 Sales Market Share by Countries (2015-2020)
Table 70. Middle East & Africa Somatostatin Receptor Type 2 Revenue by Countries (2015-2020) (USD Million)
Table 71. Middle East & Africa Somatostatin Receptor Type 2 Revenue Market Share by Countries (2015-2020)
Table 72. Global Somatostatin Receptor Type 2 Sales by Type (2015-2020) (K Pcs)
Table 73. Global Somatostatin Receptor Type 2 Sales Share by Type (2015-2020)
Table 74. Global Somatostatin Receptor Type 2 Revenue by Type (2015-2020) (USD Million)
Table 75. Global Somatostatin Receptor Type 2 Revenue Share by Type (2015-2020)
Table 76. Global Somatostatin Receptor Type 2 Sales by Application (2015-2020) (K Pcs)
Table 77. Global Somatostatin Receptor Type 2 Sales Share by Application (2015-2020)
Table 78. Global Somatostatin Receptor Type 2 Sales Forecast by Regions (2021-2025) (K Pcs)
Table 79. Global Somatostatin Receptor Type 2 Market Share Forecast by Regions (2021-2025)
Table 80. Global Somatostatin Receptor Type 2 Sales Forecast by Type (2021-2025) (K Pcs)
Table 81. Global Somatostatin Receptor Type 2 Market Share Forecast by Type (2021-2025)
Table 82. Global Somatostatin Receptor Type 2 Sales Forecast by Application (2021-2025)
Table 83. Global Somatostatin Receptor Type 2 Market Share Forecast by Application (2021-2025)
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Somatostatin Receptor Type 2 Picture
Figure 2. Global Sales Market Share of Somatostatin Receptor Type 2 by Type in 2019
Figure 3. CRN-00808 Picture
Figure 4. Lanreotide Acetate Picture
Figure 5. PRL-2903 Picture
Figure 6. Others Picture
Figure 7. Somatostatin Receptor Type 2 Sales Market Share by Application in 2018
Figure 8. Hormonal Disorder Picture
Figure 9. Oncology Picture
Figure 10. Metabolic Disorder Picture
Figure 11. Others Picture
Figure 12. Global Somatostatin Receptor Type 2 Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Somatostatin Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Somatostatin Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Somatostatin Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Somatostatin Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Somatostatin Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Somatostatin Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Somatostatin Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Somatostatin Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Somatostatin Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Somatostatin Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Somatostatin Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Somatostatin Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Somatostatin Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Somatostatin Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Somatostatin Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Somatostatin Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Somatostatin Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Somatostatin Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Somatostatin Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Somatostatin Receptor Type 2 Sales Market Share by Manufacturer in 2019
Figure 33. Global Somatostatin Receptor Type 2 Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Somatostatin Receptor Type 2 Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Somatostatin Receptor Type 2 Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Somatostatin Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 38. Global Somatostatin Receptor Type 2 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Somatostatin Receptor Type 2 Revenue Market Share by Regions (2015-2020)
Figure 40. Global Somatostatin Receptor Type 2 Revenue Market Share by Regions in 2018
Figure 41. North America Somatostatin Receptor Type 2 Sales and Growth Rate (2015-2020)
Figure 42. Europe Somatostatin Receptor Type 2 Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Somatostatin Receptor Type 2 Sales and Growth Rate (2015-2020)
Figure 44. South America Somatostatin Receptor Type 2 Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Somatostatin Receptor Type 2 Sales and Growth Rate (2015-2020)
Figure 46. North America Somatostatin Receptor Type 2 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Somatostatin Receptor Type 2 Sales Market Share by Countries (2015-2020)
Figure 48. North America Somatostatin Receptor Type 2 Sales Market Share by Countries in 2018
Figure 49. North America Somatostatin Receptor Type 2 Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Somatostatin Receptor Type 2 Revenue Market Share by Countries in 2018
Figure 51. United States Somatostatin Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 52. Canada Somatostatin Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 53. Mexico Somatostatin Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Europe Somatostatin Receptor Type 2 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Somatostatin Receptor Type 2 Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Somatostatin Receptor Type 2 Revenue Market Share by Countries in 2019
Figure 57. Germany Somatostatin Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. UK Somatostatin Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. France Somatostatin Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. Russia Somatostatin Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. Italy Somatostatin Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Asia-Pacific Somatostatin Receptor Type 2 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Somatostatin Receptor Type 2 Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Somatostatin Receptor Type 2 Revenue Market Share by Regions 2019
Figure 65. China Somatostatin Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Somatostatin Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. Korea Somatostatin Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. India Somatostatin Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Southeast Asia Somatostatin Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. South America Somatostatin Receptor Type 2 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Somatostatin Receptor Type 2 Sales Market Share by Countries in 2019
Figure 72. South America Somatostatin Receptor Type 2 Revenue Market Share by Countries in 2019
Figure 73. Brazil Somatostatin Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 74. Argentina Somatostatin Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 75. Middle East and Africa Somatostatin Receptor Type 2 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Somatostatin Receptor Type 2 Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Somatostatin Receptor Type 2 Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Somatostatin Receptor Type 2 Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Somatostatin Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 80. Egypt Somatostatin Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. Turkey Somatostatin Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. South Africa Somatostatin Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Global Somatostatin Receptor Type 2 Sales and Growth Rate (2021-2025) (K Pcs)
Figure 84. Global Somatostatin Receptor Type 2 Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Somatostatin Receptor Type 2 Market Forecast (2021-2025) (K Pcs)
Figure 86. Europe Sales Somatostatin Receptor Type 2 Market Forecast (2021-2025) (K Pcs)
Figure 87. Asia-Pacific Sales Somatostatin Receptor Type 2 Market Forecast (2021-2025) (K Pcs)
Figure 88. South America Sales Somatostatin Receptor Type 2 Market Forecast (2021-2025) (K Pcs)
Figure 89. Middle East & Africa Sales Somatostatin Receptor Type 2 Market Forecast (2021-2025) (K Pcs)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
ソマトスタチン受容体4型の世界市場 2020年 Market Overview The global Somatostatin Receptor Type 4 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Somatostatin Rec…- ソマトスタチン・ソマトスタチン類似体の世界市場 2020年 Market Overview The global Somatostatin and Somatostatin Analogs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Somatos…
- ソマトスタチン薬の世界市場 2020年 Market Overview The global Somatostatin Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Somatostatin Drugs market …
- アルファ2Cアドレナリン受容体の世界市場 2020年 Market Overview The global Alpha 2C Adrenergic Receptor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Alpha 2C Adrener…
- 胃抑制性ポリペプチド受容体の世界市場 2020年 Market Overview The global Gastric Inhibitory Polypeptide Receptor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Gastr…